(Q35631419)

9 August 2017

1 reference

title

Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention (English)

1 reference

9 August 2017

Can M Nguyen

1

1 reference

9 August 2017

Robert A Harrington

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2003

1 reference

American journal of cardiovascular drugs

9 August 2017

published in

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

423-436

1 reference

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200303060-00005

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200303060-00005

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200303060-00005

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200303060-00005

10.2165/00129784-200303060-00005

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1046623559

0 references

1 reference